India IPOs: Grey Market Premiums Deceive Investors on Listing Value

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorKavya Nair|Published at:
India IPOs: Grey Market Premiums Deceive Investors on Listing Value
Overview

India's IPO market is struggling with unreliable Grey Market Premiums (GMP). In 2025, nearly a third of mainboard IPOs listed below their peak GMP-predicted gains, even with high subscriptions. This shows a growing divide: retail investors use GMP as a quick speculative tool, while institutions focus on fundamental analysis, governance, and proper valuation. Regulators are warning against these informal signals, urging investors to make informed decisions as the market matures from speculation to sustainable growth.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

India's IPO market is experiencing a growing disconnect between unofficial Grey Market Premiums (GMP) and actual listing prices. This trend, evident throughout 2025, shows that speculative sentiment is increasingly overshadowing fundamental analysis. As these unofficial indicators become less reliable, a significant information gap is emerging, primarily affecting retail investors.

The 2025 IPO cycle and early 2026 performance data clearly illustrate GMP's fading accuracy. Nearly a third of mainboard IPOs in 2025 listed below the gains their peak GMPs had suggested, even for heavily oversubscribed issues. For example, Lenskart Solutions saw its GMP collapse by roughly 90% before listing, while Tata Capital's GMP hinted at a 6-7% gain but opened with only a 1.2% premium. This suggests GMP, derived from an unregulated and opaque over-the-counter market, is failing to capture true price discovery driven by institutional order books.

This situation highlights a stark contrast between retail investors and institutions. Retail investors, keen on quick listing profits, heavily rely on GMP as a speculative shortcut. A 2024 SEBI study found that 54% of shares allotted to non-anchor investors were sold within a week, a pattern linked to GMP's influence. In 2025, IPOs with GMPs over ₹200 saw retail over-subscription rates averaging 180x, compared to 45x for those below ₹100. Institutional investors, however, bypass GMP entirely. Mutual funds and foreign portfolio managers focus instead on the anchor book, relative valuations, earnings potential, promoter share dilution, and company governance.

Retail investors' continued reliance on GMP stems partly from a lack of easy access to information. Details in draft red herring prospectuses, complex peer valuation analyses, and leverage assessments require time and expertise many retail investors may not have. GMP offers a simpler shortcut, a single number that appears to reduce uncertainty, often amplified by social media. This reliance can lead to the 'winner's curse': demand driven by sentiment inflates prices, causing drops after listing when speculation fades. India's IPO market has grown significantly, with over 200 million demat accounts, but this growth has also made investors more prone to these shortcut decisions during market volatility.

India's primary market saw record fundraising in 2025, with IPOs raising about ₹1.95 trillion. However, average listing gains dropped to about 10% in 2025 from 30% in 2024. Early 2026 trends show further slowing, with some IPOs even listing below their issue price. This slowdown is causing a market shift, with more focus on disciplined valuations and strong business models. SEBI has repeatedly warned investors about unofficial pricing signals, pointing out execution risks and promoting investor education. The regulator plans to introduce a 30-day delay on market data for educational use to stop it being used for investment advice, aiming to clearly separate education from financial advice.

When GMP shifts from casual talk to a main investment tool, it brings significant risks. The unofficial and unregulated nature of the grey market means participants face counterparty risks, as trades rely on trust, not legal backing. High Networth Individuals (HNIs) using leverage can inflate subscription numbers without real long-term interest, distorting demand. Past IPOs show that while initial gains can be attractive, long-term returns often lag broader market indices. Companies with weak fundamentals or those easily swayed by sentiment can use GMP hype for overvalued listings that crash once speculation fades. SEBI's repeated warnings are a key signal that relying on these informal metrics carries major execution risk.

As India's IPO market matures, the focus is shifting to sustainable value, requiring more transparency and realistic pricing. A strong pipeline of potential issuers, including big names like Reliance Jio and PhonePe, is expected in 2026, but market players stress the need for selectivity. The trend shows a move from speculative listings to companies with profitability, strong cash flow, and scalable business models. Regulators are pushing for better disclosures and clearer explanations of valuations to bridge the information gap. The market's future depends on investors looking beyond speculative premiums and basing decisions on fundamental analysis and good governance, crucial for long-term growth.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.